Alvimopan Capsule
Product Images NDC 0254-3012

5 FDA label images from Par Health Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Alvimopan (NDC 0254-3012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Alvimopan (Alvimopan 1)

Alvimopan (Alvimopan 1)
Chemical structure of alvimopan dihydrate, showing its molecular configuration including two water molecules as part of the hydrate form.*
FDA Label Image

Figure 1 (Alvimopan 2)

Figure 1 (Alvimopan 2)
A line graph showing the estimated probability of achieving an endpoint over time in hours after the end of surgery, comparing Alvimopan and placebo. The x-axis represents hours after surgery (0 to 264), and the y-axis shows the estimated probability from 0 to 1. The graph features two lines: a dashed line for Alvimopan and a solid line for placebo, with Alvimopan generally showing higher probability values over time.*
FDA Label Image

Figure 2 (Alvimopan 3)

Figure 2 (Alvimopan 3)
A Kaplan-Meier curve comparing the estimated probability of achieving an endpoint over time (hours after end of surgery) for Alvimopan versus Placebo. The graph shows two lines: a dashed line for Alvimopan and a solid line for Placebo, with the vertical axis labeled as 'Estimated Probability of Achieving Endpoint' ranging from 0 to 1, and the horizontal axis labeled as 'Hours After End of Surgery' spanning 0 to 264 hours.*
FDA Label Image

Carton (Alvimopan 4)

Carton (Alvimopan 4)
Packaging label for Alvimopan capsules 12 mg, a hospital-use oral prescription drug by Par Health USA, LLC. The label displays the product name, strength, and dosage form as unit-dose capsules, with a quantity of 30 (6 x 5). It includes storage instructions and a warning to keep out of reach of children. The label also shows the manufacturer details and barcodes.*
FDA Label Image

Blister (Alvimopan 5)

Blister (Alvimopan 5)
Label for Alvimopan Capsule 12 mg, marked for hospital use only. The label shows it is manufactured for Par Health USA, Rochester, MI, and made in India. Each segment includes the NDC 0254-3012-78 and a barcode, intended for push-through packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.